Dr. Zhao is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
14225 Newbrook Dr
Chantilly, VA 20151Phone+1 301-891-5165Fax+1 301-891-5141
Education & Training
- Cleveland Clinic FoundationFellowship, Cytopathology, 2012 - 2013
- MedStar Health/Georgetown University HospitalResidency, Pathology-Anatomic and Clinical, 2009 - 2012
- Washington Hospital CenterInternship, Transitional Year, 2008 - 2009
- China Medical University ShenyangClass of 1998
Certifications & Licensure
- VA State Medical License 2019 - 2026
- GA State Medical License 2020 - 2025
- MD State Medical License 2013 - 2025
- OH State Medical License 2011 - 2025
- DC State Medical License 2022 - 2024
- American Board of Pathology Pathology - Anatomic/Pathology - Clinical
- American Board of Pathology Cytopathology
Publications & Presentations
PubMed
- 1 citationsA Rare Case of Persistent Multifocal Cribriform-Morular Thyroid Carcinoma.William Kuenstner, Po Zhao, Wen Lee, Carlos Garcia, Kenneth D Burman
AACE Clinical Case Reports. 2024-01-16 - 10 citationsGLI1 activation is a key mechanism of erlotinib resistance in human non-small cell lung cancer.Zhouhuan Dong, Yun Wang, Vivianne W. Ding, Xiang Yan, Yali Lv
Oncology Letters. 2020-10-01 - 10 citationsDexamethasone inhibits stemness maintenance and enhances chemosensitivity of hepatocellular carcinoma stem cells by inducing deSUMOylation of HIF‑1α and Oct4Zhongmin Jiang, Chunyan Zhang, Xiaozhi Liu, Xiaofang Ma, Xiyun Bian
International Journal of Oncology. 2020-09-01
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: